Table 2.

Description of change in experimental (E) and control (C) groups between the three assessment encounters

Variable	N	E1-E2 encounter change Mean (SD)	P-Value	N	E2-E3 encounter change Mean (SD)	P- Value	N	C1-C2 encounter change Mean (SD)	P-Value	N	C2-C3 encounter change Mean (SD)	P- Value
Systolic Blood Pressure	64	−5.4 (18.2)	0.05	54	−4.4 (19.9)	0.06	59	−6.2 (80.0)	0.01	51	−2.9 (14.1)	0.12
Diastolic Blood Pressure	64	−0.6 (15.9)	0.11	54	−1.6 (9.4)	0.13	59	−1.9 (12.8)	0.07	51	−3.1 (11.7)	0.06
Heart Rate	64	1.1 (8.6)	0.36	53	3.1 (8.5)	0.01	56	2.8 (10.7)	0.05	49	0.6 (9.3)	0.38
Grip Strength	60	−0.5 (6.8)	0.69	54	0.5 (6.3)	0.46	58	−0.9 (7.9)	0.48	47	0.3 (2.7)	0.65
Timed Up and Go	64	−0.6 (4.1)	0.001	53	−0.7 (3.5)	0.04	58	−0.1 (2.6)	0.17	50	−0.9 (3.7)	0.06
Gait Speed	64	−0.2 (1.3)	0.001	53	−0.5 (1.2)	0.001	58	−0.1 (1.2)	0.04	50	−0.5 (2.3)	0.06
Four Stage Balance Test	65	0.4 (0.8)	0.001	50	0.3 (0.9)	0.02	56	−0.1 (0.7)	0.50	46	0.1 (0.9)	0.39
Five Time Sit to Stand	61	−2.2 (3.6)	0.001	48	−3.1 (3.9)	0.001	47	−0.5 (5.6)	0.03	41	−0.7 (4.8)	0.06
SPPB	64	0.9 (2.3)	0.001	47	1.5 (2.3)	0.001	53	0.8 (1.9)	0.01	45	1.1 (2.3)	0.001
STEADI Fall Risk	61	−0.2 (0.7)	0.03	49	−0.4 (0.7)	0.001	55	−01 (0.4)	0.51	46	−0.1 (0.6)	0.31
HOME FAST	53	−0.3 (1.52)	0.1	46	−0.5 (2.4)	0.16	45	0.04 (3.7)	0.25	40	−0.2 (6.2)	0.98

E1 = experimental group baseline assessment; E2 = experimental group 3-month assessment; E3 = experimental group 7-month assessment; C1 = control group baseline assessment; C2 = control group 3-month assessment; C3 = control group 7-month assessment; SD = standard deviation; SPPB = Short Physical Performance Battery. Items reaching statistical significance on P < 0.05 are italic and bold